Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04993859 · ClinicalTrials.gov registry record
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
A clinical trial of Bladder Dysfunction and Survivors of Childhood Cancer, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 152
- Enrollment target
- 1
- Study location
NCT04993859 is a study of Bladder Dysfunction and Survivors of Childhood Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 152 participants, below the 521-participant average among 4 other Bladder Dysfunction trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04993859, a study of Bladder Dysfunction and Survivors of Childhood Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Non-invasive Urodynamic Test (niUDS)
- DIAGNOSTIC_TEST Urinary proteomic screen
- OTHER Dysfunctional Voiding Symptom Score Survey (DVSS)
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2026-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04993859
The ClinicalTrials.gov registry entry for NCT04993859 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 521-participant average among 4 other Bladder Dysfunction trials with a reported enrollment target (71% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bladder Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Non-invasive Urodynamic Test (niUDS) is the first listed.
NCT04993859 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04993859 about?
NCT04993859 is a clinical study titled "Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children". The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.
What is the current status of trial NCT04993859?
This trial is currently recruiting. The enrollment target is 152 participants. The study started on 2021-06-02. Estimated completion is 2026-07-09.
What conditions does trial NCT04993859 study?
This clinical trial studies the following conditions: Bladder Dysfunction, Survivors of Childhood Cancer.
What interventions are being tested in trial NCT04993859?
The interventions under investigation include: Non-invasive Urodynamic Test (niUDS) (DIAGNOSTIC_TEST), Urinary proteomic screen (DIAGNOSTIC_TEST), Dysfunctional Voiding Symptom Score Survey (DVSS) (OTHER).
Who is sponsoring clinical trial NCT04993859?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04993859 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
RECRUITING
-
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics
RECRUITING
-
Vascularized Composite Bladder Allograft Transplantation
RECRUITING · NA
-
Concomitant Renal and Urinary Bladder Allograft Transplantation
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.